{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:20:27Z","timestamp":1787566827348,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5 \\u00D7 1.000"],"award-info":[{"award-number":["5 \\u00D7 1.000"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["28282\\u2013NCT05974475"],"award-info":[{"award-number":["28282\\u2013NCT05974475"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018429","name":"Istituto Europeo di Oncologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104095","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:11:17Z","timestamp":1784898677000},"page":"104095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunological biomarkers for precision stereotactic body radiation therapy in early-stage non-small cell lung cancer: a systematic review"],"prefix":"10.1016","volume":"98","author":[{"given":"Stefania","family":"Volpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-3028","authenticated-orcid":false,"given":"Mateusz","family":"Bilski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-3149","authenticated-orcid":false,"given":"Maria Giulia","family":"Vincini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Onza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-1297","authenticated-orcid":false,"given":"Gaia","family":"Piperno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessia","family":"Zerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cornacchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fulghieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Noberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8609-7584","authenticated-orcid":false,"given":"Eltjona","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0163-879X","authenticated-orcid":false,"given":"Konstantinos","family":"Venetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Casiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bonaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2026.104095_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104095_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Zer","year":"2025","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104095_bib3","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s00066-025-02455-3","article-title":"Long-term clinical results of early-stage lung cancer patients treated with risk-adapted stereotactic body radiotherapy using LINAC or CyberKnife: a single-institution analysis of more than 400 cases","volume":"201","author":"J\u00e1nv\u00e1ry","year":"2025","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104095_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chest.2025.06.023","article-title":"Management of patients with early-stage non-small cell lung cancer","volume":"168","author":"Howington","year":"2025","journal-title":"Chest"},{"issue":"34","key":"10.1016\/j.eclinm.2026.104095_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021715","article-title":"A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104095_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2024.3089","article-title":"Stereotactic vs hypofractionated radiotherapy for inoperable stage I non\u2013small cell lung cancer: the LUSTRE phase 3 randomized clinical trial","volume":"10","author":"Swaminath","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib8","article-title":"Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114225","article-title":"Empowering effective biomarker-driven precision oncology: a call to action","volume":"209","author":"Lawler","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eclinm.2026.104095_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241298541","article-title":"Cancer biomarkers and precision oncology: a review of recent trends and innovations","volume":"18","author":"AlDoughaim","year":"2024","journal-title":"Clin Med Insights Oncol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104095_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11864-025-01324-6","article-title":"Immunotherapy-Boosted stereotactic ablative radiotherapy in inoperable early-stage non-small cell lung cancer","volume":"26","author":"Lian","year":"2025","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12885-023-10719-3","article-title":"Association of neutrophil\u2013lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijrobp.2024.02.048","article-title":"Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiation therapy and surgery for early-stage non-small cell lung cancer","volume":"120","author":"Yan","year":"2024","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221112287","article-title":"Shortened radiation time promotes recovery from radiation-induced lymphopenia in early-stage non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"21","author":"Zhao","year":"2022","journal-title":"Technol Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104095_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241505","article-title":"Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer","volume":"15","author":"McLaughlin","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104095_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/diagnostics13020313","article-title":"Derived neutrophil-lymphocyte ratio and C-Reactive protein as prognostic factors for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"13","author":"Dong","year":"2023","journal-title":"Diagnostics"},{"issue":"42","key":"10.1016\/j.eclinm.2026.104095_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022603","article-title":"Evaluation of the prognostic value of derived neutrophil\/lymphocyte ratio in early stage non-small cell lung cancer patients treated with stereotactic ablative radiotherapy","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cllc.2015.07.007","article-title":"Pretreatment immune parameters predict for overall survival and toxicity in early-stage non\u2013small-cell lung cancer patients treated with stereotactic body radiation therapy","volume":"17","author":"Shaverdian","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104095_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JTO.0000000000000399","article-title":"Neutrophil\u2013Lymphocyte and platelet\u2013lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non\u2013small-cell lung cancer","volume":"10","author":"Cannon","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2025.08.055","article-title":"Patterns of immunity changes predict response to SABR in early non-small cell lung cancer","volume":"124","author":"Rutkowski","year":"2026","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib21","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-023-40813-w","article-title":"Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial","volume":"14","author":"Monjazeb","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2026.104095_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1426635","article-title":"Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer","volume":"15","author":"Kuncman","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104095_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/OP.22.00475","article-title":"Stereotactic body radiotherapy for the management of early-stage non\u2013small-cell lung cancer: a clinical overview","volume":"19","author":"Buchberger","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104095_bib26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jtho.2025.05.004","article-title":"Emerging role of targeted therapies combined with radiotherapy in inoperable stages I to III NSCLC: a review from the IASLC ART subcommittee","volume":"20","author":"Bowen Jones","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1228076","article-title":"The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review","volume":"13","author":"Heshmat-Ghahdarijani","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib28","article-title":"Association between the neutrophil-to-lymphocyte ratio and cancer in adults from NHANES 2005\u20132018: a cross-sectional study","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13014-024-02485-8","article-title":"Clinical implications of the serum platelet-to-lymphocyte ratio in the modern radiation oncology era: research update and literature review","volume":"19","author":"Lee","year":"2024","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104095_bib31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109934","article-title":"Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy","volume":"189","author":"Yang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lungcan.2021.01.022","article-title":"Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy","volume":"154","author":"Friedes","year":"2021","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104095_bib34","article-title":"Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC","volume":"3","author":"Jing","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.eclinm.2026.104095_bib35","article-title":"Understanding the impact of radiation-induced lymphopenia: preclinical and clinical research perspectives","volume":"49","author":"Prades-Sagarra","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104095_bib36","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ijrobp.2023.01.054","article-title":"Predicting severity of radiation induced lymphopenia in individual proton therapy patients for varying dose rate and fractionation using dynamic 4-Dimensional blood flow simulations","volume":"116","author":"McCullum","year":"2023","journal-title":"Int J Radiat Oncol"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104095_bib37","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104095_bib38","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ijrobp.2023.12.046","article-title":"The next chapter in immunotherapy and radiation combination therapy: cancer-specific perspectives","volume":"118","author":"Wisdom","year":"2024","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.eclinm.2026.104095_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1554499","article-title":"Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.eclinm.2026.104095_bib40","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1158\/1078-0432.CCR-14-1138","article-title":"Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response","volume":"20","author":"Kuo","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104095_bib41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41416-023-02553-y","article-title":"Targeting serine\/glycine metabolism improves radiotherapy response in non-small cell lung cancer","volume":"130","author":"S\u00e1nchez-Castillo","year":"2024","journal-title":"Br J Cancer"},{"issue":"21","key":"10.1016\/j.eclinm.2026.104095_bib42","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non\u2013small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib43","article-title":"Author Correction: Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer","volume":"14","author":"Ohashi","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41467-025-56546-x","article-title":"Spatially mapping the tumour immune microenvironments of non-small cell lung cancer","volume":"16","author":"Desharnais","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104095_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3694","article-title":"Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: implications for distinct immunotherapy outcomes","volume":"26","author":"Fang","year":"2024","journal-title":"J Gene Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104095_bib46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1186\/s12885-023-11701-9","article-title":"Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study","volume":"23","author":"Volpe","year":"2023","journal-title":"BMC Cancer"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:30:21Z","timestamp":1787560221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S2589537026003482"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104095","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological biomarkers for precision stereotactic body radiation therapy in early-stage non-small cell lung cancer: a systematic review","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104095"}}